STERIS /$STE
1D1W1MYTD1Y5YMAX
About STERIS
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
- Ticker
- $STE
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 17,937
- Headquarters
- Mentor, United States
- Website
- www.steris.com
STERIS Metrics
BasicAdvanced
$22B
27.45
$8.18
0.91
$2.52
1.12%
Price and volume
Market cap
$22B
Beta
0.91
52-week high
$269.44
52-week low
$195.14
Average daily volume
694K
Dividend rate
$2.52
Financial strength
Current ratio
1.906
Quick ratio
1.165
Long term debt to equity
22.852
Total debt to equity
28.312
Dividend payout ratio (TTM)
30.68%
Interest coverage (TTM)
18.97%
Profitability
EBITDA (TTM)
1,634.6
Gross margin (TTM)
44.42%
Net profit margin (TTM)
13.33%
Operating margin (TTM)
19.04%
Effective tax rate (TTM)
25.79%
Revenue per employee (TTM)
$340,000
Management effectiveness
Return on assets (TTM)
6.80%
Return on equity (TTM)
11.39%
Valuation
Price to earnings (TTM)
27.455
Price to revenue (TTM)
3.646
Price to book
3.04
Price to tangible book (TTM)
14.93
Price to free cash flow (TTM)
23.779
Free cash flow yield (TTM)
4.21%
Free cash flow per share (TTM)
9.445
Dividend yield (TTM)
1.12%
Forward dividend yield
1.12%
Growth
Revenue change (TTM)
8.37%
Earnings per share change (TTM)
25.29%
3-year revenue growth (CAGR)
9.78%
10-year revenue growth (CAGR)
9.52%
3-year earnings per share growth (CAGR)
89.85%
10-year earnings per share growth (CAGR)
16.73%
3-year dividend per share growth (CAGR)
10.26%
10-year dividend per share growth (CAGR)
9.68%
What the Analysts think about STERIS
Analyst ratings (Buy, Hold, Sell) for STERIS stock.
STERIS Financial Performance
Revenues and expenses
STERIS Earnings Performance
Company profitability
STERIS News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.